Resident #3, who has end-stage renal disease and diabetes, receives hemodialysis three times a week on Tuesdays, Thursdays and Saturdays. Her physician had ordered 10 milligrams daily of Amlodipine Besylate, a calcium channel blocker used to treat high blood pressure in patients with chronic kidney disease.
But on March 19, dialysis staff documented a medication change on the resident's communication form: decrease Amlodipine to 5 milligrams every day. Federal inspectors found the nursing home never implemented the reduction.
Nearly a month later, on April 13, the resident was still receiving 10 milligrams daily instead of the ordered 5 milligrams.
When inspectors questioned the Director of Nursing at 2:30 that afternoon, she acknowledged the Amlodipine dose "was not correct" but said she "was not sure why it had not been changed."
The medication error represents a breakdown in communication between the dialysis center and nursing home staff. Dialysis patients require careful medication monitoring because their kidney function affects how drugs are processed in their bodies.
Inspectors also discovered missing dialysis communication forms for March 17 and March 21, suggesting gaps in documentation that could have contributed to the oversight.
The Regional Nurse Consultant confirmed the missing paperwork the next morning, telling inspectors that dialysis communication sheets for March 19 and March 21 were absent from the resident's medical record. She also acknowledged that the Amlodipine dose "was clarified with the doctor, and it should have been 5 mgs every day and had not been."
Resident #3's care plan from May 2025 outlined her need for regular hemodialysis and included interventions to administer medications as ordered and encourage her to attend scheduled dialysis appointments. The plan recognized her complex medical needs related to end-stage renal disease.
The physician's original order from March 19 included specific parameters for holding the medication: don't give if systolic blood pressure drops below 100 or pulse falls below 60. These safety measures become more critical when patients receive incorrect doses.
For dialysis patients like Resident #3, medication adjustments often occur based on lab results and clinical assessments made during treatment sessions. Communication forms serve as the primary method for dialysis centers to relay these changes to nursing home staff.
The facility's failure to implement the dose reduction meant the resident received double the prescribed amount of blood pressure medication for weeks. Amlodipine works by relaxing blood vessels to lower blood pressure, and excessive doses can cause dangerous drops in blood pressure, especially in patients with kidney disease.
Missing documentation compounds the problem by creating gaps in the resident's medical record that could affect future care decisions. When dialysis communication forms disappear, nursing staff lose critical information about treatment changes and patient responses.
The inspection found that nursing home staff failed to follow professional standards of practice in managing the resident's medications. Despite having systems in place for dialysis communication, the facility couldn't explain why a straightforward dose reduction went unimplemented for nearly a month.
Federal inspectors classified the violation as causing minimal harm or potential for actual harm, but medication errors in vulnerable populations like dialysis patients can escalate quickly. The resident's complex medical conditions, including diabetes and end-stage renal disease, make accurate medication management essential for preventing complications.
The case illustrates how communication breakdowns between healthcare providers can put residents at risk, even when the required paperwork and protocols exist.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Lincoln County Care Center from 2026-04-15 including all violations, facility responses, and corrective action plans.
